| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.98B | 43.75B | 42.29B | 41.92B | 43.46B | 49.08B |
| Gross Profit | 3.68B | 3.66B | 3.92B | 4.30B | 3.42B | 2.80B |
| EBITDA | 1.45B | 1.42B | 1.20B | 2.26B | 1.52B | 846.35M |
| Net Income | 750.46M | 642.78M | 292.55M | 897.50M | 748.17M | 497.46M |
Balance Sheet | ||||||
| Total Assets | 15.51B | 16.64B | 18.58B | 16.86B | 20.89B | 20.40B |
| Cash, Cash Equivalents and Short-Term Investments | 5.11B | 6.59B | 5.97B | 4.19B | 6.33B | 6.24B |
| Total Debt | 5.48B | 5.97B | 8.09B | 6.36B | 11.44B | 11.10B |
| Total Liabilities | 8.26B | 9.23B | 11.50B | 9.91B | 14.50B | 14.63B |
| Stockholders Equity | 7.25B | 7.40B | 7.08B | 6.93B | 6.38B | 5.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.05B | 1.03B | 4.56B | 746.34M | -604.69M |
| Operating Cash Flow | 0.00 | 3.07B | 1.03B | 4.58B | 747.66M | -602.42M |
| Investing Cash Flow | 0.00 | -39.26M | -70.61M | -15.93M | 7.76M | 1.85M |
| Financing Cash Flow | 0.00 | -2.46B | 473.04M | -6.77B | -866.74M | 862.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥98.87B | 6.87 | ― | 1.72% | 47.42% | 80.08% | |
80 Outperform | ¥339.98B | 15.35 | 5.77% | 3.28% | 10.58% | -7.25% | |
77 Outperform | ¥89.16B | 15.26 | 12.96% | 1.36% | 19.33% | 20.49% | |
71 Outperform | ¥513.17B | 22.63 | ― | 1.02% | 26.11% | 36.35% | |
71 Outperform | ¥5.80B | 17.05 | ― | 4.47% | -3.12% | 67.60% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | ¥123.90B | -7.98 | ― | 2.45% | 1.60% | -74.21% |